Literature DB >> 21729664

Effective role of hormonal therapy in metastatic primary neuroendocrine breast carcinoma.

Amanpreet Buttar1, Kriti Mittal, Ashraf Khan, Venu Bathini.   

Abstract

Primary neuroendocrine carcinoma (PNEC) of the breast is extremely rare.(1) Because of the rarity of this cancer, long-term prognosis, biologic behavior, and treatment are not well known. PNEC can have high expression of estrogen receptor (ER) and progesterone receptor (PR). It is important to differentiate PNEC of the breast from other metastatic diseases to the breast because of the differences in treatment. We herein report the successful treatment of a patient with PNEC of the breast and high expression of ER and PR by means of hormonal therapy.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21729664     DOI： 10.1016/j.clbc.2011.02.006

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN： 1526-8209            Impact factor:   3.225


  7 in total

Review 1.  Primary neuroendocrine breast cancer, how much do we know so far?

Authors:  Homam Alkaied; Kassem Harris; Basem Azab; Qun Dai
Journal:  Med Oncol       Date:  2012-04-01       Impact factor: 3.064

Review 2.  Neuroendocrine Carcinoma of the Breast: Current Evidence and Future Perspectives.

Authors:  Alessandro Inno; Giuseppe Bogina; Monica Turazza; Laura Bortesi; Simona Duranti; Alberto Massocco; Giuseppe Zamboni; Giovanni Carbognin; Filippo Alongi; Matteo Salgarello; Stefania Gori
Journal:  Oncologist       Date:  2015-12-09

3.  Primary Neuroendocrine Carcinoma of the Breast with Clinical Features of Inflammatory Breast Carcinoma: A Case Report and Literature Review.

Authors:  Do Hyung Lee; Ah Young Park; Bo Kyoung Seo; Young Sik Kim; Ki Yeol Lee; Sang Hoon Cha
Journal:  J Breast Cancer       Date:  2015-12-23       Impact factor: 3.588

4.  Neuroendocrine breast carcinoma metastatic to the liver: Report of a case and review of the literature.

Authors:  Konstantinos Manes; Spyridon Delis; Nikolaos Papaspyrou; Ioanna Ghiconti; Christos Dervenis
Journal:  Int J Surg Case Rep       Date:  2014-06-24

Review 5.  Neuroendocrine breast carcinoma: a rare but challenging entity.

Authors:  Elena Trevisi; Anna La Salvia; Lorenzo Daniele; Maria Pia Brizzi; Giovanni De Rosa; Giorgio V Scagliotti; Massimo Di Maio
Journal:  Med Oncol       Date:  2020-07-25       Impact factor: 3.064

6.  A case report on metastatic ileal neuroendocrine neoplasm to the breast masquerading as primary breast cancer: A diagnostic challenge and management dilemma.

Authors:  Alexandros Papalampros; Eustratia Mpaili; Demetrios Moris; Helen Sarlanis; Marina Tsoli; Evangelos Felekouras; Dimitrios T Trafalis; Michael Kontos
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

Review 7.  Neuroendocrine Neoplasms of the Breast: The Latest WHO Classification and Review of the Literature.

Authors:  Yukinori Ozaki; Sakiko Miura; Ryosuke Oki; Teppei Morikawa; Keita Uchino
Journal:  Cancers (Basel)       Date:  2021-12-31       Impact factor: 6.639
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.